| Literature DB >> 20205837 |
David Cameron1, John N Lavis, G Emmanuel Guindon, Tasleem Akhtar, Francisco Becerra Posada, Godwin D Ndossi, Boungnong Boupha.
Abstract
BACKGROUND: A questionnaire could assist researchers, policymakers, and healthcare providers to describe and monitor changes in efforts to bridge the gaps among research, policy and practice. No questionnaire focused on researchers' engagement in bridging activities related to high-priority topics (or the potential correlates of their engagement) has been developed and tested in a range of low- and middle-income countries (LMICs).Entities:
Year: 2010 PMID: 20205837 PMCID: PMC2825187 DOI: 10.1186/1478-4505-8-4
Source DB: PubMed Journal: Health Res Policy Syst ISSN: 1478-4505
Response rates by country and health topic
| Country | Insecticide-treated nets to prevent malaria | Intrauterine devices for contraception | Oral rehydration therapy to prevent dehydration in children with diarrhea | TB-DOTS to treat patients with tuberculosis | Total |
|---|---|---|---|---|---|
| China | - | 25/25 | - | 25/36 | 50/61 |
| Ghana | 16/20 | - | 3/6 | - | 19/26 |
| India | - | - | 16/40 | 17/59 | 33/99 |
| Iran | - | - | - | 24/37 | 24/37 |
| Kazakhstan | - | 29/30 | - | - | 29/30 |
| Laos | 20/22 | 18/20 | - | - | 38/42 |
| Mexico | - | 22/50 | - | 26/40 | 48/90 |
| Pakistan | - | 13/37 | - | 13/37 | |
| Senegal | 16/16 | - | 18/18 | - | 34/34 |
| Tanzania | 20/28 | - | - | - | 20/28 |
| All | 72/86 | 94/125 | 50/101 | 92/172 | 308/484 |
Note that the numerator includes those who completed the questionnaire and indicated in the questionnaire that they undertook KTE activities (but not exclusively commercialization activities) in the hope that research on the topic would be considered and/or acted upon outside the scholarly community. The denominator includes all researchers surveyed less those who completed the questionnaire and indicated that they did not undertake KTE activities in the hope that research on the topic would be considered and/or acted upon outside the scholarly community.
Internal consistency and pattern response
| Conceptual domains | # of items | Cronbach's alpha | Proportion who provided the same ordinal scale response for each item within a conceptual domain |
|---|---|---|---|
| Push - What is "transferred" to target audiences outside the scholarly community (e.g., journal articles, systematic reviews, and messages that specified possible action) | 7 | 0.89 | 0.15 |
| Push - To whom is research being transferred and with what investments in fine-tuning the approach to them (e.g., tailored the content of mailings or e-mails to specific target audiences) | 7 | 0.90 | 0.17 |
| Push - By whom is research being transferred and with what investments in supporting their efforts (e.g., identified and worked with credible messengers) | 8 | 0.91 | 0.38 |
| Push - How is research knowledge being transferred to particular target audiences, and specifically using what "passive" strategies (e.g., mailed or emailed brief summaries or messages without an explicit request) | 15 | 0.93 | 0.13 |
| Push - How is research knowledge being transferred to particular target audiences, and specifically using interactions related to the research process (e.g., interacted when developing a specific research question, objectives or hypothesis) | 7 | 0.94 | 0.27 |
| Push - How is research knowledge being transferred to particular audiences, and specifically using interactions outside the research process (e.g., interacted through events organized by them or their organization or through informal conversations) | 10 | 0.90 | 0.10 |
| Push - With what efforts to evaluate their KTE activities (e.g., assessed any changes in their target audiences actual -- i.e., objectively measured -- behaviour that may be attributable to their KTE activities) | 7 | 0.96 | 0.28 |
| Facilitating "user pull" - What passive strategies have been used to facilitate user pull (e.g., provided access to a searchable database of articles, reports, syntheses or reviews on the topic) | 5 | 0.89 | 0.23 |
| Facilitating "user pull" - What active strategies have been used to facilitate user pull (e.g., developed capacity of target audiences to acquire research on the topic through searchable databases) | 4 | 0.91 | 0.35 |
| Exchange - What exchange efforts are undertaken (e.g., established or maintained long-term partnerships related to the topic with target audience representatives, involved target audience representatives in establishing the overall direction of their or their organization's research on the topic) | 6 | 0.92 | 0.26 |
Assessment of construct validity using criterion-related measures
| Question | Item | Strength | Item | Question |
|---|---|---|---|---|
| Please indicate how often you (and/or your organization working in conjunction with you or on your behalf) performed each of these knowledge transfer and exchange (KTE) activities related to the health topic: | Provided reprints/copies of articles published in scientific journals to your target audiences ( | gamma = 0.626 | Same as column 2 | Please indicate how often during a |
| Provided syntheses of the research literature to your target audiences ( | gamma = 0.648 | Same as column 2 | ||
| Provided formal systematic reviews of the research literature to your target audiences | gamma = 0.657 | Same as column 2 | ||
| Developed brief summaries of articles and/or research reports for your target audiences ( | gamma = 0.478 | Same as column 2 | ||
| Developed messages for your target audiences that specified possible action | gamma = 0.452 | Same as column 2 | ||
| Developed reports, summaries or messages that provided examples or demonstrations of how specific target audiences could use the research | gamma = 0.364 | Same as column 2 | ||
| Mailed or e-mailed to your target audiences a | gamma = 0.629 | Same as column 2 | ||
| Accepted requests from journalists to participate in interviews or debates | gamma = 0.731 | Accepted requests from journalists (radio, television, newspaper, etc.) to participate in interviews or debates | ||
| Please indicate how often you (and/or your organization working in conjunction with you or on your behalf) interacted with representatives and/or members of your target audiences about research on the health topic in the following contexts | Interacted through government-sponsored meetings involving your target audiences | gamma = 0.692 | Same as column 2 | Please indicate how often during a |
| Interacted through events organized by you and/or your organization | gamma = 0.556 | Same as column 2 | ||
| Interacted through informal conversations with your target audiences | gamma = 0.556 | Same as column 2 | ||
Assessment of construct validity using convergent measures
| Question | Item | Strength | Item | Question |
|---|---|---|---|---|
| Please indicate how often you (and/or your organization working in conjunction with you or on your behalf) performed each of these knowledge transfer and exchange (KTE) activities related to the health topic: | Provided reprints/copies of articles published in scientific journals to your target audiences ( | Gamma = 0.296 | Had access to at least five scientific journals indexed in | Please indicate whether you had access to the following sources of information when you were involved in research on the health topic and in knowledge transfer and exchange (KTE) activities related to the health topic: |
| Same as above | gamma = 0.410 | Had access to at least five scientific journals published locally, nationally or regionally (full text paper or full text electronic) | ||
| Provided formal systematic reviews of the research literature to your target audiences | gamma = 0.333 | Same as above | ||
| Please indicate how often you (and/or your organization working in conjunction with you or on your behalf) interacted (e.g., through teleconferences or face to-face meetings involving a small number of people) with representatives and/or members of your target audiences | Interacted when developing a specific research question, objectives or hypothesis | gamma = 0.502 | Involved representatives and/or members of your target audiences in establishing the | Please indicate how often you (and/or your organization working in conjunction with you or on your behalf) performed each of these knowledge transfer and exchange (KTE) activities related to the health topic: |
| Please indicate how often you (and/or your organization working in conjunction with you or on your behalf) performed activities (e.g., conducted workshops or seminars) to increase the capacity of your target audiences to use research on the health topic: | Developed capacity of target audiences to | gamma = 0.398 | Had access to at least five scientific journals indexed in | Please indicate whether you had access to the following sources of information when you were involved in research on the health topic and in knowledge transfer and exchange (KTE) activities related to the health topic: |